Worldwide, pre-eclampsia is one of the leading causes of illness and death for mothers-to-be and their babies according to the World Health Organisation. It affects two to eight per cent of pregnancies worldwide, and five to eight per cent of those affected in developing countries go on to develop eclampsia – a condition that causes […]
http://www.a1m.se/wp-content/uploads/2017/02/pregnancy.jpg5501200Emily Headhttp://www.a1m.se/wp-content/uploads/2015/01/A1M_logo3.pngEmily Head2017-02-15 10:32:172017-02-15 10:32:17The global impact of pre-eclampsia
On 24 November 2016, Action on Pre-eclampsia (APEC) held an expert meeting in London, which A1M Pharma scientists attended. There aren’t many charities for pre-eclampsia so it was an important event for A1M Pharma to attend to meet health professionals and scientists working in the area and patients affected by the condition. APEC is a […]
http://www.a1m.se/wp-content/uploads/2016/10/blood_pressure-1.jpg5501200Emily Headhttp://www.a1m.se/wp-content/uploads/2015/01/A1M_logo3.pngEmily Head2016-10-10 14:42:412016-10-10 14:58:17A1M – a treatment for pre-eclampsia?
Emily Headcompleted her undergraduate degree in Biological Sciences in 2012 and also has a Masters degree in Science Communication.